Patents Examined by Ali Soroush
  • Patent number: 10814004
    Abstract: The invention belongs to the field of macromolecules and biomedical materials, and relates to a polymer, a block copolymer comprising the polymer as a segment, methods for preparing the polymer and for preparing the block copolymer, a micelle particle or a vesicle particle prepared from the block copolymer, and a composition comprising the polymer, the block copolymer, the micelle particle and/or the vesicle particle. The polymer provided in the invention can be used as a novel biomedical material in in the fields such as pharmaceutical formulations, immunological formulations, and gene delivery reagents.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: October 27, 2020
    Assignee: Yingu Pharmaceutical Co., Ltd.
    Inventors: Yuanyuan Pan, Shuqiang Zhao, Wenzhan Yu
  • Patent number: 10799530
    Abstract: A method for reducing the weight of an overweight or obese subject comprising administering a therapeutically effective amount of a composition comprising 64Zn-enriched zinc. A method for preventing or reducing weight gain comprising administering an effective amount of a composition comprising 64Zn-enriched zinc.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: October 13, 2020
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 10792248
    Abstract: An aqueous suspension preparation that comprises a macrolide antibacterial agent as an active component. The aqueous suspension preparation is characterized by comprising nanoparticles of a macrolide antibacterial agent and a dispersion stabilizer; an aqueous suspension in which the average particle size of nanoparticles is 500 nm or less and the D90 particle size is 1,500 nm or less; a parenterally administered pharmaceutical composition that comprises this aqueous suspension preparation; an injection preparation; and eye drops or ear drops, more specifically, eye drops for the treatment or prevention of inflammatory diseases of the eye or ear drops for the treatment or prevention of inflammatory diseases of the ear.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: October 6, 2020
    Assignee: ACTIVUS PHARMA CO., LTD.
    Inventors: Takahiro Tada, Kazuhiro Kagami, Shiro Yokota, Kenta Kikuchi
  • Patent number: 10786596
    Abstract: In various aspects, the present disclosure pertains to methods of treating or preventing bleeding at a tissue site comprising applying a chitosan powder composition to the tissue site. In various aspects, the present disclosure pertains to chitosan powder compositions for application to a tissue site, where the powder compositions comprise a chitosan salt, a crosslinked chitosan, a derivatized chitosan, or a combination thereof. In various aspects, the disclosure pertains to catheter assemblies, which are preloaded with a chitosan powder composition and which are configured to deliver the chitosan powder composition a tissue site.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: September 29, 2020
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Gerald Fredrickson, Amanda L. Smith, Andrew Pic, Sophia Gervasio, Lauren Lydecker
  • Patent number: 10781177
    Abstract: The present invention provides a compound represented by formula (I) (in the formula, R1 to R4 each represent a hydrogen atom, an unsubstituted or G1-substituted C1-6 alkyl group or the like, A represents an oxygen atom or the like, Cy represents a C6-10 aryl group or the like), an N-oxide compound thereof, a tautomer or salt thereof. The present invention also provides an agricultural and horticultural fungicide, harmful organism control agent and insecticidal/acaricidal agent containing at least one compound selected from the group consisting of a compound represented by formula (I), a tautomer and salt thereof, as an active ingredient.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: September 22, 2020
    Assignee: Nippon Soda Co., Ltd.
    Inventors: Takaaki Teranishi, Shinya Uesusuki, Jun Iwata, Takuya Kamada, Youhei Munei, Satoshi Nishimura, Hiroki Inoue, Tetsuya Tanaka, Yuka Nakamura, Yusuke Fukushima, Tomomi Kobayashi, Shinya Koubori
  • Patent number: 10744200
    Abstract: The present invention relates to an improved process for production of Aluminium phosphate (AlPhos) gel wherein the solutions of aluminium salt and alkaline phosphate salt are added to water by maintaining the pH under stirring to obtain the precipitate, followed by sterilization of the said precipitate and finally obtaining the Aluminum phosphate gel.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: August 18, 2020
    Assignee: BIOLOGICAL E LIMITED
    Inventors: Ravi Ganapathy, Nagireddy Gade, Manish Manohar, Vikram Madhusadan Paradkar, Mahima Datla
  • Patent number: 10744348
    Abstract: The invention relates to photocurable compositions comprising at least one inorganic gelling agent.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: August 18, 2020
    Assignee: L'ORÉAL
    Inventors: Christopher Michael Macneill, XianZhi Zhou, Tsang-Min Huang, Aline Aude Guimont, Chunhua Li, Hy Si Bui, Ronni Lynn Weinkauf
  • Patent number: 10736824
    Abstract: One aspect of the invention is a new foam which includes a liquid having a plurality of bubbles therein and a plurality of particles suspended therein. The foam is made in a dispenser that suspends the bubbles in the liquid. The liquid may be a single liquid with particles therein or may be made from two liquids which are mixed together. The particles may be such that, prior to foaming the particles sink, float or are suspended in the liquid.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: August 11, 2020
    Assignee: DEB IP LIMITED
    Inventors: Shaun Kerry Matthews, Stewart Banks, Kara Catherine Stonehouse, Pierre Bruno Grascha, Cynthia Louise Grimadell, Elizabeth Ann Bowley
  • Patent number: 10729626
    Abstract: A storage-stable solid composition comprising a tooth whitening effective amount of a particulated inorganic salt of peroxymonosulfate, and a particulated drying agent.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: August 4, 2020
    Assignee: Colgate-Palmolive Company
    Inventors: Shashank Vishwanath Potnis, Rolando B. Plata, Manisha Jha, Devendra Chavan
  • Patent number: 10695382
    Abstract: The invention provides compositions based on either medicinal honey containing broad spectrum antibacterial activities of peroxide, polyphenols and methylglyoxal, or an effective amount of an active anti-inflammatory ingredient of mineral solids fortified with methylglyoxal antibacterial activity, or a mixture of both for the treatment of wounds; and methods of treating a wound, comprising contacting a wound with any one of the above compositions or a wound dressing containing any one of the above compositions.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: June 30, 2020
    Assignee: SANMELIX LABORATORIES, INC.
    Inventor: Kenneth A. Sabacinski
  • Patent number: 10675292
    Abstract: The invention pertains to the use of one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof in the manufacture of a composition for treating, preventing or reducing the risk of occurrence of white matter lesions, white matter hyperintensities (WMH), Leukoaraiosis or periventricular white matter disease in elderly not suffering from a neurodegenerative disorder, preferably non-demented elderly and elderly not suffering from Alzheimer's Disease. It was found that with the compositions according to the invention Nogo-A protein levels could be controlled, particularly suppressed or reduced.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: June 9, 2020
    Assignee: N.V. NUTRICIA
    Inventors: Nick Van Wijk, Robert Johan Joseph Hageman, Mehmet Cansev
  • Patent number: 10668069
    Abstract: A pharmaceutical composition including neptinib is provided. The composition includes neptinib or a pharmaceutically acceptable salt thereof, and an excipient at a low risk of compatibleness. Furthermore, the pharmaceutical composition of the present invention may also include pharmaceutically acceptable organic acid or inorganic acid as a stabilizer. The content of impurity A maintains a non-significant increase in the long-term and accelerated stability investigation for the pharmaceutical composition.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: June 2, 2020
    Assignee: SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSITUTE CO., LTD
    Inventors: Jingan Yang, Zhiguo Wang, Jing Cui, Xiaorou Liu
  • Patent number: 10653616
    Abstract: Disclosed in the present specification are: a composition for preventing hair loss or promoting hair growth, containing ginseng-derived exosome-like vesicles; and a method for preparing the composition. The ginseng-derived exosome-like vesicles can have a diameter of 20-500 nm and can be isolated from ginseng root. The composition contains ginseng-derived exosome-like vesicles as active ingredients, thereby having an effect of inducing hair growth by activating dermal papilla cells (DPCs).
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: May 19, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Eun-Jeong Choi, Yonghee Lee, Seung Hyun Shin, Kyeonghwan Hwang, Eun-Gyung Cho, Tae Ryong Lee
  • Patent number: 10656166
    Abstract: A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Patent number: 10653720
    Abstract: A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 19, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Patent number: 10645934
    Abstract: The present invention relates to a novel species of Enterobacter, Enterobacter sp. 638, and to its use in connection, for example, with a method for increasing growth in a plant, increasing biomass in a plant, increasing fruit and/or seed productivity in a plant, increasing disease tolerance and/or resistance in a plant, and increasing drought tolerance and/or resistance in a plant, as compared to a control or wild-type plant grown under identical conditions without application of the inventive method or composition. The methods include applying an effective amount of a composition, which includes an isolated culture of Enterobacter sp. 638, to the plant.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: May 12, 2020
    Assignee: BROOKHAVEN SCIENCE ASSOCIATES/BROOKHAVEN NATIONAL LABORATORY
    Inventors: Lee Newman, Daniel van der Lelie, Safiyh Taghavi
  • Patent number: 10639271
    Abstract: Embodiments of a finishing powder of this disclosure include a rice powder and an iron-oxide pigment, with no talc or parabens, that eliminates transfer of wet or sticky spray tan bronzer to clothing, hands, or between opposing folds or creases of skin. The finishing powder may be applied full body—for example 85% to 95% of total body surface area—by way of a brush, being too thick in its consistency to spray. The powder may be blown from the brush to the body. An amount of the mixture applied to a user may be in a range ¾ teaspoon to 2¼ teaspoon. The powder immediately coats the spray tanning solution and remains dry to the touch. Because of its thicker consistency, the powder does not dissipate and remains on the skin up to 24 hours or until the user showers.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: May 5, 2020
    Inventors: Erin Tietsort, Jennifer Roudabush
  • Patent number: 10617559
    Abstract: The present invention relates to a nanocomposite ocular device that can release drugs within a close distance to the ocular surface and provide controlled and sustained release of the drug at a constant rate. The device can achieve both optical and medical functions. The device comprises a drug, one or more reservoir domains, and a barrier layer configured to block the drug diffusion paths from the reservoir domain to the ocular surface in the eye of the subject, wherein the drug partitions between the reservoir domain and the barrier layer, and the equilibrium drug solubility in the reservoir domain is at least five folds higher than that in the barrier layer.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: April 14, 2020
    Assignee: Lynthera Corporation
    Inventors: Arthur Jing-Min Yang, Roman C. Domszy, Jeffry Chung-Hwang Yang
  • Patent number: 10610544
    Abstract: A method of improving insulin resistance by using a supplement may include: administering the supplement including lysine, zinc, and vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: April 7, 2020
    Assignee: Lysulin, Inc.
    Inventor: John Burd
  • Patent number: 10610467
    Abstract: Disclosed are: a lightening composition comprising ginseng-derived exosome-like vesicles; and a method for producing the ginseng-derived exosome-like vesicles. The ginseng-derived exosome-like vesicles may have a diameter of between 20 and 500 nm, and may be isolated from ginseng root. Because the composition comprises the ginseng-derived exosome-like vesicles as an active ingredient, said composition is effective in preventing, improving or treating skin pigmentation conditions such as liver spots, freckles, lentigo, birth marks and melanoma by effectively suppressing the production of melanin.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: April 7, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Suh-Yeon Choi, Eun-Jeong Choi, Bum-Ho Bin, Kyeonghwan Hwang, Eun-Gyung Cho, Tae Ryong Lee